STERIS plc
NYSE:STE

Watchlist Manager
STERIS plc Logo
STERIS plc
NYSE:STE
Watchlist
Price: 214.34 USD -0.66% Market Closed
Market Cap: 21.2B USD
Have any thoughts about
STERIS plc?
Write Note

Intrinsic Value

The intrinsic value of one STE stock under the Base Case scenario is 224.78 USD. Compared to the current market price of 214.34 USD, STERIS plc is Undervalued by 5%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

STE Intrinsic Value
224.78 USD
Undervaluation 5%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
STERIS plc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for STE cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about STE?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about STERIS plc

Provide an overview of the primary business activities
of STERIS plc.

What unique competitive advantages
does STERIS plc hold over its rivals?

What risks and challenges
does STERIS plc face in the near future?

Has there been any significant insider trading activity
in STERIS plc recently?

Summarize the latest earnings call
of STERIS plc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for STERIS plc.

Provide P/S
for STERIS plc.

Provide P/E
for STERIS plc.

Provide P/OCF
for STERIS plc.

Provide P/FCFE
for STERIS plc.

Provide P/B
for STERIS plc.

Provide EV/S
for STERIS plc.

Provide EV/GP
for STERIS plc.

Provide EV/EBITDA
for STERIS plc.

Provide EV/EBIT
for STERIS plc.

Provide EV/OCF
for STERIS plc.

Provide EV/FCFF
for STERIS plc.

Provide EV/IC
for STERIS plc.

Show me price targets
for STERIS plc made by professional analysts.

What are the Revenue projections
for STERIS plc?

How accurate were the past Revenue estimates
for STERIS plc?

What are the Net Income projections
for STERIS plc?

How accurate were the past Net Income estimates
for STERIS plc?

What are the EPS projections
for STERIS plc?

How accurate were the past EPS estimates
for STERIS plc?

What are the EBIT projections
for STERIS plc?

How accurate were the past EBIT estimates
for STERIS plc?

Compare the revenue forecasts
for STERIS plc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of STERIS plc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of STERIS plc against its competitors.

Analyze the profit margins
(gross, operating, and net) of STERIS plc compared to its peers.

Compare the P/E ratios
of STERIS plc against its peers.

Discuss the investment returns and shareholder value creation
comparing STERIS plc with its peers.

Analyze the financial leverage
of STERIS plc compared to its main competitors.

Show all profitability ratios
for STERIS plc.

Provide ROE
for STERIS plc.

Provide ROA
for STERIS plc.

Provide ROIC
for STERIS plc.

Provide ROCE
for STERIS plc.

Provide Gross Margin
for STERIS plc.

Provide Operating Margin
for STERIS plc.

Provide Net Margin
for STERIS plc.

Provide FCF Margin
for STERIS plc.

Show all solvency ratios
for STERIS plc.

Provide D/E Ratio
for STERIS plc.

Provide D/A Ratio
for STERIS plc.

Provide Interest Coverage Ratio
for STERIS plc.

Provide Altman Z-Score Ratio
for STERIS plc.

Provide Quick Ratio
for STERIS plc.

Provide Current Ratio
for STERIS plc.

Provide Cash Ratio
for STERIS plc.

What is the historical Revenue growth
over the last 5 years for STERIS plc?

What is the historical Net Income growth
over the last 5 years for STERIS plc?

What is the current Free Cash Flow
of STERIS plc?

Discuss the annual earnings per share (EPS)
trend over the past five years for STERIS plc.

Business Breakdown

STERRIS plc is a globally recognized leader in the field of infection prevention, surgical, and critical care solutions, committed to enhancing patient safety and healthcare efficiency. With a rich history spanning over 100 years, the company operates in more than 60 countries, offering a diverse range of products and services tailored to meet the needs of healthcare providers. STERIS’s innovative technologies, including sterilization and disinfection equipment, surgical tables, and integrated surgical suites, position it as a vital partner for hospitals and medical facilities striving to uphold high standards of patient care. This focus on innovation not only drives customer loyalty but als...

Read More
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
STERIS plc

Current Assets 1.9B
Cash & Short-Term Investments 172.2m
Receivables 923.3m
Other Current Assets 842.3m
Non-Current Assets 8.3B
PP&E 2.1B
Intangibles 6.2B
Other Non-Current Assets 60.3m
Current Liabilities 805.5m
Accounts Payable 235.1m
Accrued Liabilities 353.7m
Other Current Liabilities 216.7m
Non-Current Liabilities 2.8B
Long-Term Debt 2.2B
Other Non-Current Liabilities 687m
Efficiency

Earnings Waterfall
STERIS plc

Revenue
5.1B USD
Cost of Revenue
-2.9B USD
Gross Profit
2.2B USD
Operating Expenses
-1.3B USD
Operating Income
933.4m USD
Other Expenses
-498.6m USD
Net Income
434.8m USD

Free Cash Flow Analysis
STERIS plc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

In its second quarter, STERIS reported a 7% increase in total revenue, maintaining momentum from the fiscal year start. However, gross margins dipped to 43.7%, partly due to labor inflation and productivity challenges, leading to an EBIT margin of 22.2%. Looking ahead, STERIS expects 6% to 7% constant currency organic revenue growth and adjusted earnings per share between $9.05 and $9.25 for the fiscal year. Healthcare revenue is projected to grow mid- to high single digits, despite capital equipment sales expected to remain flat, while AST anticipates high single-digit growth. STERIS also aims for free cash flow around $700 million, with capital expenditures at approximately $360 million.

What is Earnings Call?
Fundamental Scores

STE Profitability Score
Profitability Due Diligence

STERIS plc's profitability score is 52/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive 3-Years Revenue Growth
Positive Revenue Growth Forecast
52/100
Profitability
Score

STERIS plc's profitability score is 52/100. The higher the profitability score, the more profitable the company is.

STE Solvency Score
Solvency Due Diligence

STERIS plc's solvency score is 66/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
66/100
Solvency
Score

STERIS plc's solvency score is 66/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

STE Price Targets Summary
STERIS plc

Wall Street analysts forecast STE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for STE is 257.06 USD with a low forecast of 232.3 USD and a high forecast of 278.25 USD.

Lowest
Price Target
232.3 USD
8% Upside
Average
Price Target
257.06 USD
20% Upside
Highest
Price Target
278.25 USD
30% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for STE?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for STE is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

STE Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

STERIS plc Logo
STERIS plc

Country

Ireland

Industry

Health Care

Market Cap

21.2B USD

Dividend Yield

1.02%

Description

STERIS Plc engages in the provision of healthcare and life science product and service solutions. The firm offers a mix of consumable products, such as detergents, gastrointestinal (GI) endoscopy accessories, barrier product solutions, and other products and services, including: equipment installation and maintenance, microbial reduction of medical devices, dental instruments and tools, instrument and scope repair solutions, laboratory testing services, outsourced reprocessing, and capital equipment products, such as sterilizers and surgical tables, automated endoscope reprocessors, and connectivity solutions such as operating room (OR) integration. The firm operates through four reportable business segments: Healthcare, Applied Sterilization Technologies, Life Sciences and Dental. Its Healthcare segment focused on sterile processing departments and procedural centers, such as operating rooms, endoscopy suites, and renal dialysis centers.

Contact

DUBLIN
Block a Riverside IV, 70 Sir John Rogerson's Quay
+35312322000.0
www.steris.com

IPO

2015-11-03

Employees

13 000

Officers

President, CEO & Director
Mr. Daniel A. Carestio
Senior VP & CFO
Mr. Michael J. Tokich
Senior VP, General Counsel & Secretary
Mr. John Adam Zangerle
SVP & Chief Human Resources Officer
Ms. Mary Clare Fraser
Senior VP & President of Healthcare
Mr. Cary L. Majors
VP & Chief Accounting Officer
Ms. Karen L. Burton
Show More
Vice President of Investor Relations & Corporate Communications
Julie Winter
Senior VP & GM of Life Sciences
Ms. Julia K. Madsen
Senior VP & GM of Dental
Mr. Andrew Xilas
Senior VP & GM of AST
Mr. Kenneth E. Kohler
Show Less

See Also

Discover More
What is the Intrinsic Value of one STE stock?

The intrinsic value of one STE stock under the Base Case scenario is 224.78 USD.

Is STE stock undervalued or overvalued?

Compared to the current market price of 214.34 USD, STERIS plc is Undervalued by 5%.

Back to Top